About
Team
Pipeline
OPN-2853
OPN-7486
OPN-6602
OPN-9627
OPN-TEAD
OPN-FMRP
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
Publications & Posters
Select PROGRAMS
All Programs
OPN-2853
(6)
OPN-51107
(17)
OPN-7486
(5)
Select Dates
All Dates
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
January 9, 2017
Publication
Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling
AUTHORS
Hayakawa, et al
Programs
OPN-7486
https://doi.org/10.1016/j.ccell.2016.11.005
December 2, 2016
Poster
Response and Resistance to Bromodomain Inhibition in Acute Myeloid Leukemia
AUTHORS
Huang, et al
Programs
OPN-51107
Download PDF
July 15, 2016
Poster
Broad Anti-Tumor Activity of a Novel BET Bromodomain Inhibitor
AUTHORS
Ma, et al
Programs
OPN-51107
Download PDF
December 16, 2015
Presentation
A novel inhibitor of BET family bromodomains demonstrates in vivo and in vitro potency in B-cell malignancy
AUTHORS
El-Gamal, et al
Programs
OPN-51107
Download PDF
December 3, 2015
Poster
Efficacy and Mechanismof Action of the Novel Bromodomain Inhibitor, PLX51107, in B Cell Malignancies
AUTHORS
Mead, et al
Programs
OPN-51107
Download PDF
April 15, 2015
Publication
Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome
AUTHORS
Datta-Mitra, et al
Programs
OPN-7486
https://doi.org/10.1371/journal.pone.0121626
previous
1
2
3